TLSA
Tiziana Life Sciences Ltd
NASDAQ · Healthcare · Biotechnology · GB
$1.02
+4.67%Next report
Analyst consensus
- Next report date
- Sep 18, 2026
- EPS estimate
- -$0.08
- Revenue estimate
- —
Latest reported
- Last report date
- May 1, 2026
- EPS actual
- -$0.22
- EPS estimate
- -$0.11
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -234.3%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 7, 2026